Unipolar depressive disorder in adolescence is common worldwide but often unrecognised. The incidence, notably in girls, rises sharply after puberty and, by the end of adolescence, the 1 year prevalence rate exceeds 4%.

The burden of depression is highest in low-income and middle-income countries. Depression is associated with morbidity, and heightens suicide risk.

The strongest risk factors for depression in adolescents are:

- family history of depression
- exposure to psychosocial stress

Factors that interact to increase risk through hormonal and perturbed neural pathways include:

- inherited risks
- developmental factors
- sex hormones
- psychosocial adversity

References:

Depression in adolescence. Prof Anita Thapar et al. The Lancet, Volume 379, Issue 9820, Pages 1056 - 1067, 17 March 2012.

Image source: OpenClipArt.org

Source:
http://feeds.feedburner.com/CasesBlog

Here are my suggestions for some of the top articles in medicine for July 2012:

Participation in sport is associated with a 20-40% reduction in all-cause mortality. Exercise is a fifth vital sign! http://goo.gl/gyxYf

Renal denervation to treat resistant hypertension: Guarded optimism - CCJM http://goo.gl/svAvZ

Dengue: A reemerging concern for travelers. There is no antiviral treatment - CCJM http://goo.gl/gY6DO

POLST: An improvement over traditional advance directives - CCJM http://goo.gl/NhhbX POLST = Physician Orders for Life-Sustaining Treatment

Tonsillectomy changes: More children are operated for sleep disordered breathing and fewer for recurrent pharyngitis http://goo.gl/UXTfO

Bariatric surgery provides sustained weight loss, major improvements in severely obese individuals with diabetes type 2 http://goo.gl/OkV61

Twitter Use at American Society of Clinical Oncology Annual Meetings: 14-40 doctors generated 29% of meeting dialogue http://goo.gl/fw94I

Tweeting the Meeting: An In-Depth Analysis of Twitter Activity at Kidney Week 2011 - PLoS ONE http://goo.gl/eOmLO

Is your cat hosting a human suicide parasite? Toxoplasma gondii in chicagotribune http://goo.gl/oMW8M

How safe is your hospital? Consumer Reports magazine rates best (and worst) hospitals http://goo.gl/uHcTh

Conservatives Are Happier Than Liberals, and Extremists Are Happiest of All - NYTimes http://goo.gl/h67w9

Chronic hyperglycaemia and microvascular disease contribute to cognitive dysfunction, mental and motor slowing in both DM 1 and 2 http://goo.gl/hTTcK

5-10% of people per year with prediabetes will progress to diabetes (same proportion converts back to normoglycemia) http://goo.gl/oYbTk

Suicide is second to only accidental death as the leading cause of mortality in young men across the world. High-lethality methods of suicide are preferred by young men: hanging and firearms in high-income countries, pesticide poisoning in the Indian subcontinent, and charcoal-burning in east Asia. Lancet, 2012, http://goo.gl/DqMfF

Ethics of mitochondrial donation discussed in The Lancet http://goo.gl/JAVFC

Hepatitis E virus (HEV) was discovered during the Soviet occupation of Afghanistan in the 1980s, after an outbreak of unexplained hepatitis at a military camp. A pooled faecal extract from affected soldiers was ingested by a member of the research team. He became sick, and the new virus (named HEV), was detected in his stool by electron microscopy. Globally, HEV is the most common cause of acute viral hepatitis. http://goo.gl/vkaGB

The seventh cholera pandemic began in 1961 and still affects 3-5 million people each year, killing 120 000 http://goo.gl/bz07X

Psychiatry's identity crisis - The Lancet http://goo.gl/XfsM6

Paralympic medicine - Lancet review - 20 sports at Summer Paralympic Games, 5 at Winter Paralympic Games http://goo.gl/rpJhI

The articles were selected from my Twitter and Google Reader streams. Please feel free to send suggestions for articles to clinicalcases@gmail.com and you will receive an acknowledgement in the next edition of this publication.

Source:
http://feeds.feedburner.com/CasesBlog

Public release date: 23-Jul-2012 [ | E-mail | Share ]

Contact: Rachel Seroka rseroka@aan.com 612-928-6129 American Academy of Neurology

MINNEAPOLIS Watching videos on YouTube may be a new way to show the treatment for a common cause of vertigo, which often goes untreated by physicians, according to a study published in the July 24, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology.

Benign paroxysmal positional vertigo (BPPV) is an inner ear disorder that is a common cause of dizziness.

"This type of vertigo can be treated easily and quickly with a simple maneuver called the Epley maneuver, but too often the maneuver isn't used, and people are told to 'wait it out' or given drugs," said study author Kevin A. Kerber, MD, of the University of Michigan Health System in Ann Arbor and a member of the American Academy of Neurology. "We found that accurate video demonstrations of the maneuver that health care providers and people with vertigo can use are readily available on YouTube."

For the study, Kerber and his colleagues searched YouTube for videos showing the Epley maneuver and rated their accuracy. They also reviewed the comments posted regarding the videos to see how the videos were used.

"It was good to see that the video with the most hits was the one developed by the American Academy of Neurology when it published its guideline recommending the use of the Epley maneuver in 2008 and then posted on YouTube by a lay person," Kerber said. "But it was also good that the majority of the videos demonstrated the maneuver accurately."

Some comments showed that health care providers are using the videos as a prescribed treatment or to help patients learn about the maneuver. People with dizziness also seem to be using the videos to treat themselves.

"One shortcoming of the videos was that they did not include information on how to diagnose BPPV, and some of the comments indicate that people who do not have BPPV may be trying these maneuvers because of dizziness from other causes," Kerber said. "Despite this, we found it encouraging to think that YouTube could be used to disseminate information about this maneuver and educate more people about how to treat this disorder." Kerber and his colleagues are currently working on projects to test the effectiveness of video interventions on patient outcomes.

The disorder is likely caused by loose calcium carbonate crystals that move in the sensing tubes of the inner ear. The maneuver moves the calcium crystals out of the sensing tube and into another inner chamber of the ear, where they do not cause symptoms.

See the original post:
Is YouTube a prescription for vertigo?

Dr. Henry Echiverri, neurologist, Edward Neurosciences Institute.

storyidforme: 34017862 tmspicid: 12447744 fileheaderid: 5660247

Updated: July 24, 2012 2:02PM

Neurologist Henry Echiverri recently joined the Edward Neurosciences Institute. Dr. Echiverri is board certified in psychiatry, neurology and vascular neurology (stroke). He comes to Edward from NeuroMed Clinic in Warrenville where he was president and clinic director. Echiverri earned his medical degree from the University of the Philippines College of Medicine in Manila.

After spending time in surgical residencies at Philippine General Hospital in Manila and Northwest Hospital in Chicago, he completed a transitional internal medicine year at Edward Hines Jr. VA Hospital, followed by neurology residencies at Loyola University Medical Center and Hines VA Hospital.

Echiverri is a member of the American Academy of Neurology, American Academy of Electrodiagnostic Medicine, American Academy of Pain Management and American Heart Association. He was an Advisory Committee member of the Illinois CAPTURE (Care and Prevention Treatment Utilization Registry) Stroke Program.

Visit http://www.edward.org/neuro or call 630-527-7730 to learn about Dr. Echiverri and the Edward Neurosciences Institute.

See original here:
Dr. Echiverri joins Edward Neurosciences Institute

Performed in front of a live TV audience, Deep Purple storm through 'Child In Time', featuring the classic Mark II line up of Gillan/Glover/Lord/Paice/Blackmore:

From Jon Lord's official website:

Jon Lord has sadly passed away, July 16, 2012

It is with deep sadness we announce the passing of Jon Lord, who suffered a fatal pulmonary embolism today, Monday 16th July at the London Clinic, after a long battle with pancreatic cancer. Jon was surrounded by his loving family.

Jon Lord, the legendary keyboard player with Deep Purple co-wrote many of the bands legendary songs including Smoke On The Water and played with many bands and musicians throughout his career.

Best known for his Orchestral work Concerto for Group & Orchestra first performed at Royal Albert Hall with Deep Purple and the Royal Philharmonic Orchestra in 1969 and conducted by the renowned Malcolm Arnold, a feat repeated in 1999 when it was again performed at the Royal Albert Hall by the London Symphony Orchestra and Deep Purple.

Jon’s solo work was universally acclaimed when he eventually retired from Deep Purple in 2002.

Jon passes from Darkness to Light.

Jon Lord 9 June 1941 – 16 July 2012.

Here is a short clip of Jon Lord receiving and responding to the presentation of the Honorary Degree (Doctor of Music) from the University of Leicester, 2011:

I had the chance to see Jon Lord at a Deep Purple concert in 2001, and he was truly amazing.

Related reading:

Jon Lord obituary | Music | The Guardian - http://goo.gl/sohGI
BBC News - Deep Purple's Jon Lord dies at 71 - http://goo.gl/qvhiq
Malc Deakin talks to Jon Lord on Vimeo - http://goo.gl/cDvjU
Jon Lord death: Deep Purple founder dies aged 71 | Mail Online - http://goo.gl/G9FzX
Jon Lord & Steve Balsamo "Child In Time", May 2010 - YouTube http://goo.gl/SU231
BBC's Last Word: Ritchie Blackmore, Rick Wakeman, Geoff Barton pay tribute to Jon Lord. Also, Jon on how he'd like to be remembered. http://goo.gl/fW3VT
GTFM's Jon Lord Special by Andy Fox http://goo.gl/WqAcc

Source:
http://feeds.feedburner.com/CasesBlog

Physicians would need to use their EMRs to meet 20 functionality objectives at minimum levels to earn bonuses and avoid penalties.

Core set (must meet all objectives listed below)

Use computerized physician order entry for medication, lab and radiology orders
Prescribe electronically
Record patient demographics
Record and chart vital signs
Record smoking status
Use clinical decision support
Incorporate clinical lab results into EMR
Generate lists of patients by specific condition
Set patient reminders for preventive and follow-up care
Provide patient portal access
Provide clinical summaries for patients
Identify education resources for patients
Use secure messaging with patients
Use medication reconciliation
Send summary of care records for referrals and care transitions
Send electronic data to immunization registries
Ensure EMR privacy and security

Menu set (must select and meet 3 objectives from the list below)

Access imaging results
Record patient family histories as structured data
Send electronic syndromic surveillance data to public health agencies
Have ability to report cancer cases to state registries
Have ability to report noncancer cases to state registries

Electronic medical record (EMR) - review of pros and cons in the Cleveland Clinic medical journal

Some negatives regarding the use of EMR:

- So far, electronic systems are not interconnectable
- Do electronic records improve or worsen the quality of care?
- Accuracy vs copying and pasting
- A third party in the examination room
- Devoid of real medical thought

A contrasting view:

- Connectivity will improve
- Staying focused on the patient, even with a computer in the room
- Doctor-doctor communication is enhanced

References:

Centers for Medicare & Medicaid Services, Electronic Health Record Incentive Program -- Stage 2, Feb. 23, 2012.
First look at the next stage of meaningful use - amednews.com

The electronic medical record: Diving into a shallow pool? CCJM.
The electronic medical record: Learning to swim. CCJM.
"The iPatient is getting wonderful care across America. The real patient wonders, "Where is everybody?" NYTimes, 2011.

Source:
http://feeds.feedburner.com/CasesBlog

Newswise MINNEAPOLIS A new guideline released by the American Academy of Neurology recommends several treatments for people with Huntingtons disease who experience choreajerky, random, uncontrollable movements that can make everyday activities challenging. The guideline is published in the July 18, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

Chorea can be disabling, worsen weight loss and increase the risk of falling, said guideline lead author Melissa Armstrong, MD, MSc, with the University of Maryland School of Medicine Department of Neurology and a member of the American Academy of Neurology.

Huntingtons disease is a complex disease with physical, cognitive and behavioral symptoms. The new guideline addresses only one aspect of the disease that may require treatment.

The guideline found that the drugs tetrabenazine (TBZ), riluzole and amantadine can be helpful and the drug nabilone may also be considered to treat chorea. The medications riluzole, amantadine and nabilone are not often prescribed for Huntingtons disease.

People with Huntingtons disease who have chorea should discuss with their doctors whether treating chorea is a priority. Huntingtons disease is complex with a wide range of sometimes severe symptoms and treating other symptoms may be a higher priority than treating chorea, said Armstrong.

Armstrong adds that it is important for patients to understand that their doctors may try drugs not recommended in this guideline to treat chorea. More research is needed to know if drugs such as those used for psychosis are effective; however, doctors may prescribe them on the basis of past clinical experience.

Learn more about the guideline at http://www.aan.com/guidelines or Huntingtons disease at http://www.aan.com/patients.

The American Academy of Neurology, an association of more than 25,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimers disease, stroke, migraine, multiple sclerosis, brain injury, Parkinsons disease and epilepsy.

For more information about the American Academy of Neurology, visit http://www.aan.com or find us on Facebook, Twitter, Google+ and YouTube.

View original post here:
AAN: New Guideline on How to Best Treat Involuntary Movements in Huntington's Disease

Public release date: 18-Jul-2012 [ | E-mail | Share ]

Contact: Rachel Seroka rseroka@aan.com 612-928-6129 American Academy of Neurology

MINNEAPOLIS Higher levels of a certain fat in the blood called ceramides may increase a person's risk of developing Alzheimer's disease, according to a study published in the July 18, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

"Our study identifies this biomarker as a potential new target for treating or preventing Alzheimer's disease," said study author Michelle M. Mielke, PhD, an epidemiologist with the Mayo Clinic in Rochester, Minn. Mielke was with Johns Hopkins University at the time of the research.

For the study, 99 women between the ages of 70 and 79 and free of dementia in the Women's Health and Aging Study II had their blood tested for levels of serum ceramides, a fatty compound found throughout the body that is associated with inflammation and cell death. The participants were placed into three groups: high, middle and low levels of ceramides. They were then followed for up to nine years. Of the 99 participants, 27 developed dementia and 18 of those were diagnosed with probable Alzheimer's disease.

The study found that women who had the highest levels of the biomarker were 10 times more likely to develop Alzheimer's disease than women with the lowest levels. Those with middle levels of the biomarker were nearly eight times more likely to develop the disease than those with the lowest levels.

"These findings are important because identifying an accurate biomarker for early Alzheimer's that requires little cost and inconvenience to a patient could help change our focus from treating the disease to preventing or delaying it," said Valory Pavlik, PhD, with the Alzheimer's Disease and Memory Disorders Center of Baylor College of Medicine in Houston and a member of the American Academy of Neurology, in an accompanying editorial.

According to Pavlik, "While a larger, more diverse study is needed to confirm these findings, projections that the global prevalence of Alzheimer's disease will double every 20 years for the foreseeable future have certainly increased the sense of urgency among researchers and health care agencies to identify more effective screening, prevention and treatment strategies."

###

The study was supported by the National Institute on Aging, the National Institute of Neurological Disorders and Stroke and the Johns Hopkins Older Americans Independence Center.

Read the original post:
New biomarker in the blood may help predict Alzheimer's disease

Here some excerpts from the 2012 review of hirsutism in women in the journal American Family Physician:

Hirsutism is excess terminal hair that commonly appears in a male pattern in women.

Although hirsutism is generally associated with hyperandrogenemia, 50% of women with mild symptoms have normal androgen levels.

Causes of hirsutism

The most common cause of hirsutism is polycystic ovary syndrome (PCOS), which accounts for 3 out of every 4 cases.

Many medications can also cause hirsutism.

In patients whose hirsutism is not related to medication use, evaluation is focused on testing for endocrinopathies and neoplasms, such:

- polycystic ovary syndrome (PCOS)
- adrenal hyperplasia
- thyroid dysfunction
- Cushing syndrome
- androgen-secreting tumors

Symptoms of hirsutism

Symptoms and findings suggestive of neoplasm include rapid onset of symptoms, signs of virilization, and a palpable abdominal or pelvic mass.

Patients without these findings who have mild symptoms and normal menses can be treated empirically.

For patients with moderate or severe symptoms, an early morning total testosterone level should be obtained, and if elevated, it should be followed by a plasma free testosterone level.

A total testosterone level greater than 200 ng per dL (6.94 nmol per L) should prompt evaluation for an androgen-secreting tumor.

Diagnosis of hirsutism

Laboratory workup may include:

- early morning total testosterone level
- plasma free testosterone level
- thyroid function tests
- prolactin level
- 17-hydroxyprogesterone level
- corticotropin stimulation test

Treatment of hirsutism

Treatment includes hair removal and pharmacologic measures.

Shaving is effective but needs to be repeated often. Evidence for the effectiveness of electrolysis and laser therapy is limited.

Laser treatment does not result in complete, permanent hair reduction, but it is more effective than other methods such as shaving, waxing, and electrolysis. It produces hair reduction for up to 6 months. The effect is enhanced with multiple treatments.

In patients who are not planning a pregnancy, first-line pharmacologic treatment should include oral contraceptives. Topical agents, such as eflornithine, may also be used.

Treatment response should be monitored for at least six months before making adjustments.

References:

Hirsutism in women. Bode D, Seehusen DA, Baird D. Am Fam Physician. 2012 Feb 15;85(4):373-80.

Management of Hirsutism (Excess Hair)

Image source: Skin layers. Wikipedia, public domain.

Source:
http://feeds.feedburner.com/CasesBlog

From Mayo Clinic YouTube channel:

Vernon Smith, M.D., an emergency room physician at Mayo Clinic in Arizona, discusses the benefits of the computerized YES Board patient tracking system which he developed over the course of several years and input from hundreds of doctors, nurses and emergency room staff while he worked at Mayo Clinic in Rochester, Minn.

According to Mayo Clinic, "the YES board reduces the time required to translate data, allowing physicians to forecast the needs of their patients and track progress. It has the capacity to walk physicians through current and past information for each patient — in addition to all patients collectively. Additionally, the YES Board helps to secure usable space and resources and detect the most at-risk patients and also helps forecast the needs of the patients in the emergency department. Plus, the YES Board can be viewed through any approved computer with an internet connection."

Source:
http://feeds.feedburner.com/CasesBlog

EmergencyLink is a free service that provides medical information and personal contacts to emergency responders - Mossberg for WSJ:

Here is the URL: http://www.emergencylink.com

The company explains how it can help if:

- You Are In An Accident. A first responder locates the EmergencyLink ID and calls EmergencyLink as instructed. EmergencyLink provides the first responder with your emergency medical information and contacts your “Emergency Contacts” as you have instructed.

- Your Child Is Missing. You can quickly create a a Missing Person report and forward it to the police. The police can immediately act on the information maximizing their chances of locating your child quickly and safely.

- Sharing Information with a Caregiver. You are able to electronically share all of the information the caregiver will need in case of an emergency. Whenever your child's profile is updated, everyone with whom you are sharing the information will be updated, no need to constantly update everyone.

- A Friend is in an Accident. If your friend is an EmergencyLink Member and is "sharing" their info with you, you can access their emergency medical information (allergies, medications, medical insurance) and forward them to the first responder.

- Co-Workers Are On A Project Away From Home. Each Member in the group agrees to share their emergency contact information with each other. If there is an emergency situation, the group has the information needed to reach each others emergency contacts.

EmergencyLink is a free 24-Hour Emergency Response Service that helps you store your important information in one location, share emergency information with family and friends and has a 24-Hour Emergency Response center to aid you in an emergency:

Source:
http://feeds.feedburner.com/CasesBlog

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/75qphh/mexico_neurology_d) has announced the addition of GlobalData's new report "Mexico Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

GlobalData's new report, Mexico Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others provides key market data on the Mexico Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Scope:

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the Mexico Neurology Devices market.

Companies Mentioned:

- Medtronic, Inc.

See more here:
Research and Markets: Mexico Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/59gjfg/israel_neurology_d) has announced the addition of GlobalData's new report "Israel Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

This new report provides key market data on the Israel Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the five market categories.

- Global corporate-level profiles of key companies operating within the Israel Neurology Devices market.

- Key players covered include Medtronic, Inc., St. Jude Medical, Inc., Stryker Corporation, Nihon Kohden Corporation, DePuy, Inc., Covidien plc and others.

Read more:
Research and Markets: Israel Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/zgk4p5/sweden_neurology_d) has announced the addition of GlobalData's new report "Sweden Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

This report provides key market data on the Sweden Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope:

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the Sweden Neurology Devices market.

- Key players covered include Medtronic, Inc., Stryker Corporation, DePuy, Inc., St. Jude Medical, Inc., Covidien plc, B. Braun Melsungen AG and others.

More:
Research and Markets: Sweden Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

The eyes are the most frequently injured body parts, followed by the fingers and hands. Here is a video from the Cleveland Clinic with some advice how to prevent these injuries:

This video discusses ways to prevent and identify heat-related illness in senior citizens:

Source:
http://feeds.feedburner.com/CasesBlog

Here are my suggestions for some of the top articles in medicine for June-July 2012:

Should You Put Sunscreen on Infants? It’s best not to use sunscreen on infants under age 6 months - FDA http://buff.ly/LxmJ0u

Guillain-Barre Syndrome - NEJM review http://buff.ly/LxmC55

Long-term use of low-dose azithromycin as an attractive adjunct treatment option for COPD http://buff.ly/LAoNVi

71% of doctors believe quality of healthcare will deteriorate over the next 5 years (19-page survey summary, PDF) http://goo.gl/Sl0wd

Americans' confidence in the U.S. medical system is around the historical average of 39% http://goo.gl/KoTqI

FDA Approves Diet Pill Belviq http://bit.ly/LCvE0o

What is So Good About Growing Old: mind gets sharper at a number of vitally important abilities http://goo.gl/6xI8M

A Lithium Battery in a Hotdog: the picture burns itself into mind - keep out of reach of small children http://buff.ly/LSmPBS

People who remember being pushed or slapped as children more likely to have depression or anxiety later in life http://goo.gl/oTt7p

Physical Punishment Has Long-Lasting Consequences on Children's Mental Health (study) http://buff.ly/LKGrl6

GSK once-daily lung drug LAMA/LABA (umeclidinium/vilanterol) showed positive results in COPD http://goo.gl/s1o0P

1 in 5 Nurses is Depressed - 18% of hospital-employed nurses have depression; twice the rate of the general public http://goo.gl/aioSn

The Medication Generation: Many young people today have now spent most of their lives on antidepressants - WSJ http://on.wsj.com/LLDuVE

Publishing a medical journal is a very profitable activity, says former BMJ Editor-in-Chief and provides examples http://goo.gl/QeaKS

Health Care Mandate Puts a "Cranky Uncle" in Every Exam Room - NYTimes http://goo.gl/v0PpH

The articles were selected from my Twitter and Google Reader streams. Please feel free to send suggestions for articles to clinicalcases@gmail.com and you will receive acknowledgement in the next edition of this publication.

Source:
http://feeds.feedburner.com/CasesBlog

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/r4856w/united_states_neur) has announced the addition of GlobalData's new report "United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

This new report provides key market data on the United States Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the United States Neurology Devices market.

- Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Cyberonics, Inc., DePuy, Inc., Stryker Corporation and others.

Read the original here:
Research and Markets: United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/8bvx75/south_africa_neuro) has announced the addition of GlobalData's new report "South Africa Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

GlobalData's new report, South Africa Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others provides key market data on the South Africa Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Scope:

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the five market categories.

- Global corporate-level profiles of key companies operating within the South Africa Neurology Devices market.

Reasons to Buy:

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

See the rest here:
Research and Markets: South Africa Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

Here is a video from the Cleveland Clinic:

Key risk factors for drowning are:

- male sex
- age of less than 14 years
- alcohol use
- low income
- poor education
- rural residency
- aquatic exposure
- risky behavior
- lack of supervision

For people with epilepsy, the risk of drowning is 15 to 19 times as high as the risk for those who do not have epilepsy.

For every person who dies from drowning, another four persons receive care in the emergency department for nonfatal drowning.

Drowning Doesn’t Look Like Drowning

- Except in rare circumstances, drowning people are physiologically unable to call out for help. The respiratory system was designed for breathing. Speech is the secondary or overlaid function. Breathing must be fulfilled, before speech occurs.

- Drowning people’s mouths alternately sink below and reappear above the surface of the water.

- The mouths of drowning people are not above the surface of the water long enough for them to exhale, inhale, and call out for help. When the drowning people’s mouths are above the surface, they exhale and inhale quickly as their mouths start to sink below the surface of the water.

- Drowning people cannot wave for help. Nature instinctively forces them to extend their arms laterally and press down on the water’s surface. Pressing down on the surface of the water, permits drowning people to leverage their bodies so they can lift their mouths out of the water to breathe.

- Throughout the Instinctive Drowning Response, drowning people cannot voluntarily control their arm movements. Physiologically, drowning people who are struggling on the surface of the water cannot stop drowning and perform voluntary movements such as waving for help, moving toward a rescuer, or reaching out for a piece of rescue equipment.

- From beginning to end of the Instinctive Drowning Response people’s bodies remain upright in the water, with no evidence of a supporting kick. Unless rescued by a trained lifeguard, these drowning people can only struggle on the surface of the water from 20 to 60 seconds before submersion occurs.

References:

Drowning Doesn’t Look Like Drowning. Mario Vittone.On Scene Magazine: Fall 2006 (page 14)
Drowning - free NEJM review, 2012 http://goo.gl/xSqLu

Source:
http://feeds.feedburner.com/CasesBlog

Here are my suggestions for some of the top articles in medicine for June 2012:

Open access to research is inevitable, says Nature editor-in-chief http://goo.gl/N3OEU

Diagnosis, treatment, and management of echinococcosis | 2012 BMJ review http://goo.gl/r65Nd

How to be a cool headed clinician. Imperturbability is an essential characteristic for doctors, but how compatible is it with empathy? BMJ http://goo.gl/X7l5y

A doctor's guide to E/M coding - How to minimize lost revenue and likelihood of an audit - ModernMedicine http://goo.gl/RT6OC

Forgotten notebooks shed light on controversial discovery of streptomycin, the first antibiotic to cure TB http://goo.gl/1au0m

Apps for the Traveler With Medical Issues - NYTimes http://goo.gl/vFJzE

Statin Use Linked to Fatigue in Randomized Trial http://goo.gl/4xv0I and http://goo.gl/U2cMh

Thiazolidinedione use is associated with increased risk for diabetic macular edema http://goo.gl/1O0Tz

"Superbug" gonorrhea, becoming untreatable, accounts for 10% of STDs in Europe - doubling since last year http://goo.gl/y5aWr

Rapid Saliva Test for Laryngopharyngeal Reflux (LPR) http://goo.gl/LEsMO and http://goo.gl/GCean

Journal offers flat fee for ‘all you can publish’ Whereas PLoS ONE charges $1,350 per paper, PeerJ users pay $299 http://goo.gl/0kArd

Ipratropium linked to increased risk of stroke in COPD, especially with concomitant use of SABAs or theophylline http://goo.gl/CEr25

Chagas Disease is “The New HIV/AIDS of the Americas” claims the journal PLoS Neglected Tropical Diseases http://goo.gl/1P1qu

Cleveland Clinic summit on Patient Experience shares presentation slides - a must-read for those interested in #HCSM http://goo.gl/EnMbK

Doctors are using electronic records more - but liking them less - Washington Post http://buff.ly/Lpb8SY

Only 6.7% of office-based physicians routinely email with patients http://buff.ly/PPdusu

5 Key Benchmarks That Could Make or Break a Physician Practice http://buff.ly/LpbskH

90% of patients prefer web-based access to health information and education. 88% want to receive email reminders when it is time for preventive or follow-up care. 72% would like to use online services to book, change or cancel physician appointments. http://buff.ly/L0jjQS

The articles were selected from my Twitter and Google Reader streams. Please feel free to send suggestions for articles to clinicalcases@gmail.com and you will receive acknowledgement in the next edition of this publication.

Source:
http://feeds.feedburner.com/CasesBlog